-+ 0.00%
-+ 0.00%
-+ 0.00%

United Therapeutics CEO Martine Rothblatt disposes of shares worth $5.1 million

PUBT·06/03/2026 20:36:22
Listen to the news
United Therapeutics CEO Martine Rothblatt disposes of shares worth $5.1 million
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 146.03 on June 2, 2026.
  • Rothblatt sold 9,500 shares on June 2 at weighted-average prices ranging from USD 535.69 to USD 543.26.
  • Directly owned common stock ended at 40,513 shares.
  • Stock options beneficially owned ended at 116,910.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000068), on June 03, 2026, and is solely responsible for the information contained therein.